Federal Court upholds Health Canada’s strict interpretation of patent listing deadline for KEYTRUDA formulation patent

Published date28 April 2021
Subject MatterPatents,Filing Deadlines,Patent Litigation,Pharmaceutical Patents,Canada,Pharmaceutical Industry,Health Canada,PMNOC Regulations,Patent Registration
AuthorAndrea Berenbaum
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT